alx-550-178
|
(2R,4R)-APDC [LY314593, (2R,4R)-4-Aminopyrrolidine-2,4-dicarboxylic acid]
|
alx-550-333-m001
|
(2S,3S,4S)-2-Methyl-2-(carboxycyclopropyl)-glycine [MCCG:alpha-Methyl-L-CCG l]
|
alx-550-186-m005
|
(2S,4R)-4-Methylglutamic acid
|
alx-550-327-m001
|
(2S,4S)-4-Methylglutamic acid . hydro-chloride
|
enz-42857
|
(6) ROX-12-ddUTP
|
enz-42856
|
(6) TAMRA-12-ddUTP
|
alx-440-001
|
(6R)-5,6,7,8-Tetrahydro-L-biopterin .dihydrochloride [(6R)-BH4.2HCl]
|
bml-p118-0500
|
(Ala97)-RII (81-99)
|
bml-p506-0001
|
(beta-Ala8)Neurokinin A (4-10)
|
bml-uw9055-0100
|
(C85A)UbcH5a (h)(rec.)(His)
|
bml-uw9065-0100
|
(C85A)UbcH5b (h)(rec.)(His)
|
bml-uw9075
|
(C85A)UbcH5c (h)(rec.)(His)
|
bml-ei384-0001
|
(D-Pro1,2)-retro-(D-HIV-TAT(48-57))
|
bml-uw0345-0001
|
(D77)Ubiquitin (Untagged)(h)(rec.)
|
alx-152-031-m001
|
(Des-Arg1)-Bradykinin [Bradykinin (2-9)]
|
alx-270-375-1
|
(E)-4-Hydroxynonenal-dimethylacetal[HNE-DA]
|
bml-uw0175-0100
|
(E93R)SUMO-1 (h)(rec.)(GST)
|
bml-uw0615-0025
|
(K6-only)Ubn-ubiquitinylated Substrate
|
bml-uw0245-0001
|
(K6R)Ubiquitin (Untagged)(h)(rec.)
|
bml-uw0620-0025
|
(K11-only)Ubn-ubiquitinylated Substrate
|
bml-uw0250-0001
|
(K11R)Ubiquitin (Untagged)(h)(rec.)
|
bml-uw0625-0025
|
(K27-only)Ubn-ubiquitinylated Substrate
|
bml-uw0255-0001
|
(K27R)Ubiquitin (Untagged)(h)(rec.)
|
bml-uw0630-0025
|
(K29-only)Ubn-ubiquitinylated Substrate
|
bml-uw0260-0001
|
(K29R)Ubiquitin (Untagged)(h)(rec.)
|
bml-uw0635-0025
|
(K33-only)Ubn-ubiquitinylated Substrate
|
bml-uw0265-0001
|
(K33R)Ubiquitin (Untagged)(h)(rec.)
|
bml-uw0640-0025
|
(K48-only)Ubn-ubiquitinylated Substrate
|
bml-uw0645-0025
|
(K63-only)Ubn-ubiquitinylated Substrate
|
bml-uw0275-0001
|
(K63R)Ubiquitin (Untagged)(h)(rec.)
|
bml-uw0205-1000
|
(KaIIR)Ubiquitin (Untagged)(h)(rec.)
|
enz-32893-6000
|
(m) anti-biotin linker (Ready-to-use)
|
enz-chm160
|
(R)-BI-2536
|
alx-550-231-m001
|
(R)-CPP [3-((R)-2-Carboxypiperazin-4yl)-propyl-1phosphonic acid]
|
bml-ei290-0200
|
(R)-Ibuprofen
|
bml-cc205
|
(R)-Roscovitine
|
alx-385-032
|
(R,S)-Equol
|
alx-550-352-m005
|
(RS)-ATPA [(RS)-alpha-Amino-3-hydroxy-5-t-butyl-4-isoxazolepropionic acid]
|
alx-550-122-m005
|
(RS)-MPPG[(RS)-alpha-Methyl-4-phosphonophenylglycine]
|
alx-550-123-m005
|
(RS)-MSPG[(RS)-alpha-Methyl-4-sulphonophenylglycine]
|
alx-550-377-m005
|
(RS)-PPG
|
alx-380-142-m001
|
(S)-(+)-Ascochin
|
alx-350-015
|
(S)-(+)-Camptothecin
|
alx-550-197-m001
|
(S)-3C4H-PG[(S)-3-Carboxy-4-hydroxyphenylglycine]
|
alx-550-120-m001
|
(S)-4C-PG[(S)-4-Carboxyphenylglycine]
|
alx-550-119
|
(S)-4C3H-PG[(S)-4-Carboxy-3-hydroxyphenylglycine]
|
alx-550-016
|
(S)-AMPA [(S)-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid]
|
alx-270-509-m005
|
(S)-CR8
|
alx-550-529
|
(S)-ESBA . HCl
|
bml-ei276-0001
|
(S)-Ibuprofen
|